SCHEMBL10174789

SCHEMBL10174789

Cc1nc2cc(-c3ccccc3)nn2c(-c2ccc(N)cc2)c1C(OC(C)(C)C)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.61
NPC1 O15118 6/20 0.46
RAB9A P51151 6/20 0.46
HPGD P15428 5/20 0.46
ALDH1A1 P00352 5/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
NFKB1 P19838 1/20 0.46
HTT P42858 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
KDM4E B2RXH2 5/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
GAA P10253 2/20 0.43
MAPT P10636 3/20 0.41
NPSR1 Q6W5P4 1/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12091025 0.94 NR1I2 (0.66) NR1I2NPC1RAB9AHPGDALDH1A1
SCHEMBL10174452 0.92 NR1I2 (0.62) NR1I2NPC1RAB9AHPGDALDH1A1
SCHEMBL470405 0.91 NR1I2 (0.60) NR1I2NPC1RAB9AHPGDALDH1A1
SCHEMBL470254 0.91 NR1I2 (0.62) NR1I2NPC1RAB9AHPGDALDH1A1
SCHEMBL10174780 0.90 NR1I2 (0.61) NR1I2NPC1RAB9AHPGDALDH1A1
SCHEMBL10175626 0.90 NR1I2 (0.65) NR1I2NPC1RAB9AHPGDALDH1A1
SCHEMBL470315 0.90 NR1I2 (0.61) NR1I2NPC1RAB9AHPGDALDH1A1
SCHEMBL12090996 0.90 NR1I2 (0.60) NR1I2NPC1RAB9AHPGDALDH1A1
SCHEMBL12091051 0.90 NR1I2 (0.60) NR1I2NPC1RAB9AHPGDALDH1A1
SCHEMBL15479182 0.89 NR1I2 (0.62) NR1I2NPC1RAB9AHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012033735-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-15 WO disclosed